Nuveen LLC Takes $55.37 Million Position in The Cooper Companies, Inc. $COO

Key Points

• Nuveen LLC has acquired 656,391 shares of The Cooper Companies, Inc., totaling approximately $55.4 million, which represents 0.33% of the company's stock.
• Analysts have varied perspectives on Cooper Companies, with target prices ranging from a low of $76.00 to a high of $100.00, alongside multiple ratings including "overweight" and "strong buy."
• Cooper Companies reported a quarterly revenue of $1 billion and an earnings per share (EPS) of $0.96, beating expectations and indicating a 6.3% revenue growth year-over-year.

Nuveen LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 656,391 shares of the medical device company's stock, valued at approximately $55,367,000. Nuveen LLC owned about 0.33% of Cooper Companies at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in COO. Sagespring Wealth Partners LLC bought a new position in shares of Cooper Companies during the fourth quarter valued at approximately $244,000. Mariner LLC boosted its holdings in shares of Cooper Companies by 10.4% in the fourth quarter. Mariner LLC now owns 34,142 shares of the medical device company's stock valued at $3,139,000 after purchasing an additional 3,220 shares during the period. XTX Topco Ltd purchased a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $824,000. Canada Post Corp Registered Pension Plan purchased a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $331,000. Finally, Guggenheim Capital LLC boosted its holdings in shares of Cooper Companies by 33.1% in the fourth quarter. Guggenheim Capital LLC now owns 6,808 shares of the medical device company's stock valued at $626,000 after purchasing an additional 1,694 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded up $0.76 on Monday, hitting $74.02. The company's stock had a trading volume of 890,245 shares, compared to its average volume of 2,150,315. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38. The firm has a fifty day moving average price of $71.92 and a 200-day moving average price of $78.84. The company has a market capitalization of $14.80 billion, a price-to-earnings ratio of 35.93, a price-to-earnings-growth ratio of 1.79 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the previous year, the firm earned $0.85 EPS. The firm's revenue was up 6.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research note on Tuesday, July 22nd. Robert W. Baird reduced their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Finally, Mizuho lowered their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.